Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Veber

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 30, 2001
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorptionR A Dodds, I E James, D Rieman, et al.
Biochemistry|January 8, 2000
Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteasesM J Bossard, T A Tomaszek, M A Levy, et al.
Journal of Medicinal Chemistry|November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsitesJ M LaLonde, B Zhao, W W Smith, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivoB J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Nature|May 5, 1983
Novel renin inhibitors containing the amino acid statineJ Boger, N S Lohr, E H Ulm, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimeticS K Thompson, W W Smith, B Zhao, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 30, 2001
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorptionR A Dodds, I E James, D Rieman, et al.
Biochemistry|January 8, 2000
Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteasesM J Bossard, T A Tomaszek, M A Levy, et al.
Journal of Medicinal Chemistry|November 7, 1998
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsitesJ M LaLonde, B Zhao, W W Smith, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivoB J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Nature|May 5, 1983
Novel renin inhibitors containing the amino acid statineJ Boger, N S Lohr, E H Ulm, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Journal of Medicinal Chemistry|October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimeticS K Thompson, W W Smith, B Zhao, et al.
Pageof 10